| For: | Garattini SK, Basile D, Cattaneo M, Fanotto V, Ongaro E, Bonotto M, Negri FV, Berenato R, Ermacora P, Cardellino GG, Giovannoni M, Pella N, Scartozzi M, Antonuzzo L, Silvestris N, Fasola G, Aprile G. Molecular classifications of gastric cancers: Novel insights and possible future applications. World J Gastrointest Oncol 2017; 9(5): 194-208 [PMID: 28567184 DOI: 10.4251/wjgo.v9.i5.194] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i5/194.htm |
| Number | Citing Articles |
| 1 |
You Jeong Heo, Charny Park, Doyeong Yu, Jeeyun Lee, Kyoung-Mee Kim. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46216-6
|
| 2 |
Silvio Ken Garattini, Debora Basile, Valli’ De Re, Giulia Brisotto, Gianmaria Miolo, Vincenzo Canzonieri, Giuseppe Aprile, Carla Corvaja, Silvia Buriolla, Enrico Garattini, Fabio Puglisi. The potential of retinoic acid receptors as prognostic biomarkers and therapeutic targets in gastric cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1453934
|
| 3 |
Linmei Lin, Wanqi Lin, Yi Zheng. Upregulation of miR-1266-5p serves as a prognostic biomarker of triple-negative breast cancer and facilitates tumor cell proliferation, migration and invasion. Nucleosides, Nucleotides & Nucleic Acids 2025; doi: 10.1080/15257770.2025.2551833
|
| 4 |
Sarad Pawar Naik Bukke, Balakrishna Vuyyala, Chandrashekar Thalluri, Ananda Kumar Chettupalli, Neha Gupta, Muhammad Ali Abdullah Almoyad, Safa A. Abdalla, Vinod Kumar Yata, Alrazi Eisa Shogar, Bayapa Reddy Narapureddy, Zohre Eftekhari, Patrick Maduabuchi Aja, Tadele Mekuriya Yadesa. Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1804164
|
| 5 |
Hung-Pin Chang, Jen-Tang Sun, Chiao-Yin Cheng, Yao-Jen Liang, Yen-Lin Chen. High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer. Life 2022; 12(5) doi: 10.3390/life12050709
|
| 6 |
Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, André Roncon Dias, Sheila Friedrich Faraj, Renan Ribeiro e Ribeiro, Tiago Biachi de Castria, Bruno Zilberstein, Venancio Avancini Ferreira Alves, Ulysses Ribeiro, Evandro Sobroza de Mello. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1. Molecular Diagnosis & Therapy 2019; 23(6) doi: 10.1007/s40291-019-00424-y
|
| 7 |
Adrian Goldiș, Sorina Tăban, Mărioara Cornianu, Ioan Romoșan, Mihaela Flavia Avram, Daniela Cornelia Lazăr. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World Journal of Gastroenterology 2018; 24(32): 3583-3616 doi: 10.3748/wjg.v24.i32.3583
|
| 8 |
Maria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, Maria Gabriella Caruso, Rosalba D'Alessandro. Integrated immune gene expression signature and molecular classification in gastric cancer: New insights. Journal of Leukocyte Biology 2020; 108(2) doi: 10.1002/JLB.4MR0120-221R
|
| 9 |
Agnieszka Pikuła, Magdalena Kwietniewska, Karol Rawicz-Pruszyński, Bogumiła Ciseł, Magdalena Skórzewska, Katarzyna Gęca, Kinga Franciszkiewicz-Pietrzak, Andrzej Kurylcio, Jerzy Mielko, Wojciech P. Polkowski. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer. Seminars in Oncology 2020; 47(2-3) doi: 10.1053/j.seminoncol.2020.04.001
|
| 10 |
Nathalia Meireles Da Costa, Luis Felipe Ribeiro Pinto, Luiz Eurico Nasciutti, Antonio Palumbo Jr.. The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers. BioMed Research International 2019; 2019 doi: 10.1155/2019/2059516
|
| 11 |
Helena Magalhães, Mário Fontes-Sousa, Manuela Machado. Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/2732408
|
| 12 |
Xiaoping Wang, Yixin Eric Yang, Lintao Jia, Qi Chen. Gastroenterological Cancer and Immunotherapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/4697670
|
| 13 |
Ekaterina Olegovna Ignatova, Evgenii Kozlov, Maxim Ivanov, Vladislav Mileyko, Sofia Menshikova, Henian Sun, Mikhail Fedyanin, Alexey Tryakin, Ivan Stilidi. Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. World Journal of Gastrointestinal Oncology 2022; 14(3): 628-645 doi: 10.4251/wjgo.v14.i3.628
|
| 14 |
Daniela Bruni, Helen K. Angell, Jérôme Galon. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature Reviews Cancer 2020; 20(11) doi: 10.1038/s41568-020-0285-7
|
| 15 |
Binyu Yang, Siying Liu, Jiemin Xie, Xi Tang, Pan Guan, Yifan Zhu, Xuemei Liu, Yunhui Xiong, Zuli Yang, Weiyao Li, Yonghua Wang, Wen Chen, Qingjiao Li, Li C. Xia. Hierarchical learning of gastric cancer molecular subtypes by integrating multi‐modal DNA‐level omics data and clinical stratification. Quantitative Biology 2024; 12(2) doi: 10.1002/qub2.45
|
| 16 |
Marie-Elodie Spaety, Alexandre Gries, Amandine Badie, Aina Venkatasamy, Benoit Romain, Christophe Orvain, Kazuyoshi Yanagihara, Koji Okamoto, Alain C. Jung, Georg Mellitzer, Sébastien Pfeffer, Christian Gaiddon. HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway. Cancers 2019; 11(11) doi: 10.3390/cancers11111747
|
| 17 |
Valli De Re, Riccardo Dolcetti. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; doi: 10.1007/978-3-030-04861-7_2
|
| 18 |
Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu. New therapeutic options opened by the molecular classification of gastric cancer. World Journal of Gastroenterology 2018; 24(18): 1942-1961 doi: 10.3748/wjg.v24.i18.1942
|
| 19 |
Archana Rastogi, Chagan Bihari, Anupama G. Patil, Kaushik Majumdar, Prasenjit Das. Surgical Pathology of the Gastrointestinal System. 2022; doi: 10.1007/978-981-16-6395-6_23
|
| 20 |
K. S. Praveen Kumar, M. N. Jyothi, Akila Prashant. CHD1 dysregulation in cancer: bridging chromatin instability, therapy resistance, and immune evasion. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10536-w
|
| 21 |
Yuanfeng Wei, Limin Gao, Xi Yang, Xiaoyu Xiang, Cheng Yi. Inflammation-Related Genes Serve as Prognostic Biomarkers and Involve in Immunosuppressive Microenvironment to Promote Gastric Cancer Progression. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.801647
|
| 22 |
Safia Samir, Hend Okasha Ahmed, Tarek M. Diab, Amr Mostafa, Hesham A. Elmeligy, Amira Kamel, Heba Khalil. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity. Open Access Macedonian Journal of Medical Sciences 2022; 10(A) doi: 10.3889/oamjms.2022.9700
|
| 23 |
Jeronimo P. A. Da Silva, Mário R. Martins, Rogerio L. dos Santos, Luciana M. da Silva, Cecilia A. C. Lima, Leuridan C. Torres, Nora M. Forones. Evaluation of platelet activation marker expression and its correlation with tumorigenesis and tumor progression in patients with gastric cancer. Journal of Surgical Oncology 2022; 126(1) doi: 10.1002/jso.26908
|
| 24 |
Jersey Heitor da S. Maués, Helem Ferreira Ribeiro, Giovanny R. Pinto, Luana de Oliveira Lopes, Letícia M. Lamarão, Carla Mariana F. Pessoa, Caroline de Fátima Aquino Moreira-Nunes, Raimundo Miranda de Carvalho, Paulo P. Assumpção, Juan A. Rey, Rommel M. Rodríguez Burbano. Gastric Cancer Cell Lines Have DifferentMYC-Regulated Expression Patterns but Share a Common Core of Altered Genes. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/5804376
|
| 25 |
Debora Basile, Francesca Simionato, Alessandro Cappetta, Silvio Ken Garattini, Giandomenico Roviello, Giuseppe Aprile. State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer. Biologics: Targets and Therapy 2021; doi: 10.2147/BTT.S290323
|
| 26 |
Fatemeh Amirmoezi, Bita Geramizadeh. Molecular Classification of Gastric Cancer With Emphasis on PDL-1 Expression: The First Report From Iran. Clinical Pathology 2022; 15 doi: 10.1177/2632010X221096378
|
| 27 |
Cheng Yan, Huijie Yang, Peng Su, Xin Li, Zhongbo Li, Dehai Wang, Yifeng Zang, Tianshi Wang, Ziping Liu, Zhuocong Bao, Shuxiao Dong, Ting Zhuang, Jian Zhu, Yinlu Ding. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene 2022; 41(48) doi: 10.1038/s41388-022-02507-3
|
| 28 |
Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone, Mario Scartozzi, Eufemia Stefania Lutrino, Davide Melisi, Lorenzo Antonuzzo, Antonio Pellegrino, Laura Ferrari, Roberto Bordonaro, Caterina Vivaldi, Lorenzo Gerratana, Silvia Bozzarelli, Roberto Filippi, Domenico Bilancia, Marco Russano, Giuseppe Aprile. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy. The Oncologist 2017; 22(12) doi: 10.1634/theoncologist.2017-0158
|
| 29 |
Shijie Duan, Pengliang Wang, Funan Liu, Hanwei Huang, Wen An, Siwei Pan, Xin Wang. Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity. Cancer Medicine 2019; 8(5) doi: 10.1002/cam4.2077
|
| 30 |
Debora Basile, Francesca Simionato, Lorenzo Calvetti, Alessandro Cappetta, Annalisa Pesavento, Marta Mongillo, Giandomenico Roviello, Gerardo Rosati, Gemma Rossi, Giuseppe Aprile. Comparing immunotherapies to other frequently used treatments of gastric cancer. Expert Review of Clinical Pharmacology 2021; 14(10) doi: 10.1080/17512433.2021.1938546
|
| 31 |
Emaan Haque, Abdullah Esmail, Ibrahim Muhsen, Haneen Salah, Maen Abdelrahim. Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer. Cancers 2022; 14(22) doi: 10.3390/cancers14225615
|
| 32 |
Ana Bermúdez, Isabel Arranz-Salas, Silvia Mercado, Juan A. López-Villodres, Virginia González, Francisca Ríus, María V. Ortega, Carmen Alba, Isabel Hierro, Diego Bermúdez. Her2-Positive and Microsatellite Instability Status in Gastric Cancer—Clinicopathological Implications. Diagnostics 2021; 11(6) doi: 10.3390/diagnostics11060944
|
| 33 |
N. E. Ogurchenok, M. Yu. Agapov, G. A. Raskin. Problematic aspects of assessing predictive markers for gastric cancer based on endoscopic biopsy samples. Review. Clinical Case in Oncology 2025; 2(3) doi: 10.62546/3034-1477-2024-2-3-7-17
|
| 34 |
Meili Gao, Fan Dang, Chun Deng. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer. European Journal of Pharmacology 2019; 859 doi: 10.1016/j.ejphar.2019.172528
|
| 35 |
Panteleimon Kountourakis, Vassilios Vassiliou, Panos Papanastasopoulos, Konstantinos Papadimitriou, Demetris Papamichael, Stavros Gkolfinopoulos. Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making?. World Journal of Gastrointestinal Oncology 2018; 10(7): 172-183 doi: 10.4251/wjgo.v10.i7.172
|
| 36 |
Marina A. Pereira, Marcus F.K.P. Ramos, Sheila F. Faraj, Andre R. Dias, Osmar K. Yagi, Bruno Zilberstein, Ivan Cecconello, Venancio A.F. Alves, Evandro S. de Mello, Ulysses Ribeiro Jr. Clinicopathological and prognostic features of Epstein‐Barr virus infection, microsatellite instability, and PD‐L1 expression in gastric cancer. Journal of Surgical Oncology 2018; 117(5) doi: 10.1002/jso.25022
|
| 37 |
Runhua Feng, Jianfang Li, Birendra K. Sah, Fei Yuan, Xiaolong Jin, Min Yan, Bingya Liu, Chen Li, Zhenggang Zhu. Overexpression of CrkL as a novel biomarker for poor prognosis in gastric cancer. Cancer Biomarkers 2019; 26(2) doi: 10.3233/CBM-192435
|
| 38 |
Seung Tae Kim, Jason K. Sa, Sung Yong Oh, Kyung Kim, Jung Yong Hong, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee. Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial. Genome Medicine 2021; 13(1) doi: 10.1186/s13073-021-00826-w
|
| 39 |
Daniele Marrelli, Karol Polom, Franco Roviello. Gastric Cancer: the 25-year R-Evolution. Updates in Surgery 2022; doi: 10.1007/978-3-030-73158-8_25
|
| 40 |
Xinmei Lin, Wenhan Shi, Zitong Zhou, Degang Li, Qiuyuan Yao, Yu Sun. Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15567-5
|
| 41 |
Giuseppe Angelico, Giulio Attanasio, Lorenzo Colarossi, Cristina Colarossi, Matteo Montalbano, Eleonora Aiello, Federica Di Vendra, Marzia Mare, Nicolas Orsi, Lorenzo Memeo. ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation. Cancers 2024; 16(11) doi: 10.3390/cancers16112062
|
| 42 |
Molecular taxonomy of gastric carcinoma. Indian Journal of Pathology and Oncology 2024; 11(3) doi: 10.18231/j.ijpo.2024.049
|
| 43 |
Esmat Abdi, Saeid Latifi‐Navid, Saber Zahri, Abbas Yazdanbod, Farhad Pourfarzi. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Medicine 2019; 8(13) doi: 10.1002/cam4.2497
|
| 44 |
Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Andre Roncon Dias, Leonardo Cardili, Renan Ribeiro e Ribeiro, Tiago Biachi de Castria, Bruno Zilberstein, Sergio Carlos Nahas, Ulysses Ribeiro, Evandro Sobroza de Mello. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients. Medical Sciences 2021; 10(1) doi: 10.3390/medsci10010004
|
| 45 |
José Garcia‐Pelaez, Rita Barbosa‐Matos, Irene Gullo, Fátima Carneiro, Carla Oliveira. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges. Molecular Oncology 2021; 15(11) doi: 10.1002/1878-0261.12948
|
| 46 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences 2022; 23(12) doi: 10.3390/ijms23126664
|
| 47 |
Manuela Machado, Helena Magalhães, Mário Fontes-Sousa. Perioperative Treatment in Gastric Cancer—Developments in Patient Selection. Journal of Cancer Therapy 2018; 9(02) doi: 10.4236/jct.2018.92011
|
| 48 |
Laura Caggiari, Gianmaria Miolo, Angela Buonadonna, Debora Basile, Davide Santeufemia, Antonio Cossu, Giuseppe Palmieri, Mariangela De Zorzi, Mara Fornasarig, Lara Alessandrini, Vincenzo Canzonieri, Giovanni Lo Re, Fabio Puglisi, Agostino Steffan, Renato Cannizzaro, Valli De Re. Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype. International Journal of Molecular Sciences 2017; 19(1) doi: 10.3390/ijms19010047
|
| 49 |
Alexey Moisseev, Eugene Albert, Dan Lubarsky, David Schroeder, Jeffrey Clark. Transcriptomic and Genomic Testing to Guide Individualized Treatment in Chemoresistant Gastric Cancer Case. Biomedicines 2020; 8(3) doi: 10.3390/biomedicines8030067
|
| 50 |
Sujin Hyung, Jihoon Ko, Minae An, Seung Tae Kim, Se Hoon Park, Jung Yong Hong, Sung Hee Lim, Kyoung-Mee Kim, Jeeyun Lee. Angiogenesis gene signatures in patient-derived tumor spheroids for genetic and tumor angiogenesis profiling. Journal of Materials Chemistry B 2025; 13(37) doi: 10.1039/D5TB00577A
|
| 51 |
Cristina Díaz del Arco, Lourdes Estrada Muñoz, Luis Ortega Medina, Ma Jesús Fernández Aceñero. Actualización en cáncer gástrico. Nuevas clasificaciones moleculares. Revista Española de Patología 2021; 54(2) doi: 10.1016/j.patol.2020.06.002
|
| 52 |
Daniele Marrelli, Karol Polom, Alessandro Neri, Franco Roviello. Clinical impact of molecular classifications in gastric cancer. Updates in Surgery 2018; 70(2) doi: 10.1007/s13304-018-0546-0
|
| 53 |
Zhiwei Sun, Chang Liu, Wen G. Jiang, Lin Ye. Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer. Computational and Structural Biotechnology Journal 2020; 18 doi: 10.1016/j.csbj.2019.12.014
|
| 54 |
Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Leonardo Cardili, André Roncon Dias, Venancio Avancini Ferreira Alves, Evandro Sobroza de Mello, Ulysses Ribeiro. Prognostic significance of microsatellite instability in patients with resectable gastric cancer. Journal of Gastrointestinal Surgery 2024; 28(10) doi: 10.1016/j.gassur.2024.07.019
|